CSPC Pharmaceutical Group Limited
CHJTF
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.69B
Close$
Share Statistics
| Market cap | $14.69 Billion |
|---|---|
| Enterprise Value | $5.98 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 25.03% |
|---|---|
| Return on Assets | 16.81% |
| Return on Invested Capital | 31.94% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.12 |
| Enterprise Value to EBIT | 0.45 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About CSPC Pharmaceutical Group Limited.
18,626 employees
CEO: Lei Cai CSPC Pharmaceutical Group Limited, primarily an investment holding entity, is dedicated to the development, production, and distribution of pharmaceutical goods. Its operations span the globe, with a significant presence in the People's ...